| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
3 companies
Doyle William F is an Executive Chairman at NovoCure Ltd with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 13 sells.
Estimated insider holdings value: $12.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 6, 2020 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 60,164 | $63.36 | $3,812,170.31 | -4.9% | |
| Mar 6, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 4,320 | $69.53 | $300,386.88 | -0.8% | |
| Feb 28, 2020 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 3,893 | $72.22 | $281,133.00 | -0.8% | |
| Jan 17, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 133,777 | $95.00 | $12,708,815.00 | -20.8% | |
| Nov 25, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 16,223 | $96.04 | $1,558,056.92 | -2.5% | |
| Nov 20, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 150,000 | $90.36 | $13,553,723.43 | -10.2% | |
| Nov 12, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 43,000 | $80.59 | $3,465,392.28 | -1.7% | |
| Jun 27, 2019 | NERV Minerva Neurosciences, Inc. | Director | Buy | 3,500 | $5.50 | $19,250.00 | +15.5% | |
| May 30, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 48,100 | $53.07 | $2,552,522.70 | -5.4% | |
| May 29, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 1,900 | $53.10 | $100,880.50 | -0.2% |